Skip to main content

Table 5 Literature overview of studies analyzing CTP-IGF scoring system

From: Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort

Cohort

Mean age ± SD (years)

Male sex (%)

Viral hepatitis (%)

Liver cirrhosis (%)

CTP class (%)

BCLC stage (%)

OS (months)

A

B

C

0

A

B

C

D

 

US training [17] n = 310

62.6 ± 11.8

70.3

44.8

62.6

71.2

25.5

2.6

6.5

8.7

9.7

63.2

7.4

13.2

US validation [17] n = 155

63.2 ± 10.8

72.9

50.3

63.6

81.3

16.1

2.6

1.3

8.4

11.0

76.8

2.5

15.7

Egyptian [26] n = 100

56.7 ± 8.7

83.0

100.0

87.0

40.0

32.0

28.0

0.0

1.0

8.0

60.0

31.0

8.6

Korean [27] n = 393

56.8 ± 9.5

77.9

91.1

48.9

85.0

14.5

0.5

20.9

40.2

9.4

29.0

0.5

Missing

German n = 216

67.6 ± 9.5

86.1

14.6

81.3

50.0

32.4

17.6

0.0

16.7

11.6

51.4

20.4

11.4